E Fund (HK) Solactive Biopharma Select Index ETF (HKG:3186)

Assets	24.62M
Expense Ratio	n/a
PE Ratio	20.00
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a
1-Year Return	n/a

Volume	80,200
Open	14.96
Previous Close	14.99
Day's Range	14.88 - 15.05
52-Week Low	12.71
52-Week High	16.95
Beta	n/a
Holdings	96
Inception Date	Mar 23, 2026

About 3186

3186.HK was created on 2026-03-23 by E Fund . The fund's investment portfolio concentrates primarily on health care equity. The investment objective is to provide investment results that, before fees and expenses, closely correspond to the performance of the Solactive Biopharma Select Index (the Index).

• Asset Class: Equity
• Category: Health Care
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 3186
• Provider: E Fund
• Index Tracked: Solactive Biopharma Select Index - HKD - Benchmark TR Net

Top 10 Holdings

27.26% of assets

Name	Symbol	Weight
Keymed Biosciences Inc.	2162	3.25%
Zai Lab Limited	9688	3.15%
InnoCare Pharma Limited	9969	2.96%
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.	6990	2.84%
Innovent Biologics, Inc.	1801	2.75%
BeOne Medicines AG	6160	2.73%
InSilico Medicine Cayman TopCo	3696	2.56%
Hansoh Pharmaceutical Group Company Limited	3692	2.42%
HUTCHMED (China) Limited	0013	2.31%
CSPC Pharmaceutical Group Limited	1093	2.29%

Data Sources: S&P Global Market Intelligence, Twelve Data, and more

Historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data. Several fund data points are also provided by Finnhub.

Last checked:

Sep 23, 2026

Data Sources Report a data error